Showing results (131-140 of 150) with videos related to
Sort By:
Pageof 15
Respiratory Medicine|December 27, 2021
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort studyColin J Adams, Shane Shapera, Christopher J Ryerson, et al.Canadian Respiratory Journal|July 23, 2016
The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis RegistryChristopher J Ryerson, Benjamin Tan, Charlene D Fell, et al.Respiratory Research|December 8, 2020
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung diseaseAlyson W Wong, Tae Yoon Lee, Kerri A Johannson, et al.Chest|November 17, 2021
Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung DiseaseAlessia Comes, Alyson W Wong, Jolene H Fisher, et al.Annals of the American Thoracic Society|May 25, 2021
Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung DiseaseKerri A Johannson, Brendan C Lethebe, Deborah Assayag, et al.Journal of Thoracic Disease|June 16, 2023
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohortVeronica Marcoux, Stacey Lok, Prosanta Mondal, et al.Respirology (Carlton, Vic.)|March 4, 2024
Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi-centre registry cohortVeronica Marcoux, Stacey D Lok, Prosanta Mondal, et al.Respiratory Research|July 9, 2021
Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung diseaseTao Chen, Amy Po Yu Tsai, Seo Am Hur, et al.The European Respiratory Journal|March 1, 2023
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based studyYet H Khor, Max Schulte, Kerri A Johannson, et al.Respiratory Medicine|April 8, 2026
Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung diseaseGiulia Nalesso, Giulia Ferranti, Daniel-Costin Marinescu, et al.Pageof 15